Innovating the treatment of COPD exacerbations: a phone interactive telesystem to increase COPD Action Plan adherence

Raquel Farias, Maria Sedeno, Danielle Beaucage, Isabelle Drouin, Isabelle Ouellet, Alexandre Joubert, Rita Abimaroun, Meena Patel, Mira Abou Rjeili, Jean Bourbeau, Raquel Farias, Maria Sedeno, Danielle Beaucage, Isabelle Drouin, Isabelle Ouellet, Alexandre Joubert, Rita Abimaroun, Meena Patel, Mira Abou Rjeili, Jean Bourbeau

Abstract

Introduction: Self-management interventions with Written Action Plans and case management support have been shown to improve outcomes in patients with chronic obstructive pulmonary disease (COPD). Novel telehealth technologies may improve self-management interventions. The objectives of this study were to determine whether the use of an interactive phone telesystem increases Action Plan adherence, improves exacerbation recovery and reduces healthcare use in a real-life practice of a COPD clinic.

Methods: Initially, 40 patients were followed by a COPD telesystem for 1 year. Detailed data from patients' behaviours during exacerbations was recorded. The telesystem use was then extended to 256 patients from a real-life COPD clinic. Healthcare utilisation for the year before and after telesystem enrolment was then assessed through hospital administrative databases.

Results: Thirty-three of the 40 patients completed the initial 1-year study. Eighty-one exacerbations were reported in the 1-year follow-up. Action Plan adherence was observed for 72% of the exacerbations and those who were adherent had a significantly faster exacerbation recovery time. The large-scale implementation of the telesystem resulted in a significant decrease in the proportion of patients with ≥1 respiratory-related emergency room (ER) visits (120 before vs 110 after enrolment, p<0.001) and with ≥1 COPD-related hospitalisations (75 before vs 65 after enrolment, p<0.001).

Discussion: COPD Written Action Plan adherence was further enhanced with the use of telehealth technologies in a specialised clinic with experience in COPD self-management. Patients followed by the telesystem recovered faster from exacerbations and had a further decrease in COPD-related ER visits and hospitalisations.

Trial registration number: NCT02275078.

Keywords: COPD; action plan adherence; exacerbations; self-management; telehealth.

Conflict of interest statement

Competing interests: JB reports grants from CIHR, Canadian Respiratory Research Network (CRRN), grants and personal fees from GLAXOSMITHKLINE, GRIFOLS, grants from AEROCRINE, grants and personal fees from BOEHRINGER INGELHEIM, ASTRAZENECA, NOVARTIS, grants from the Foundation of the MUHC, personal fees from NOVARTIS, all outside the lifespan of the submitted work.

Figures

Figure 1
Figure 1
The telesystem. Patients received regular automated calls from a computer-linked telesystem. Patients could also directly contact the telesystem at any time. During the telesystem calls, patients were asked about their general health status, which could be reported as better than usual, as usual or worse than usual. Patients were also asked if they wanted to be contacted by their curse manager. Depending on patients’ answers to the automated calls, healthcare professionals received notifications indicating patient’s health status (well-being, callback or alarm). If patient’s health status was reported as worse than usual, the telesystem programmed an automated follow-up call and captured information on patients’ symptoms, quality of life (with the COPD assessment test, CAT) and patients’ actions (treatment and healthcare use). Healthcare professionals received an alarm notification email which allowed them to follow-up with patients by phone as soon as possible. COPD, chronic obstructive pulmonary disease.
Figure 2
Figure 2
Time-to-treatment during COPD exacerbations. (A) Time to medication use (days). (B) Time to healthcare utilisation (days). Box plots from left to right: circles to the left box plots, outliers; left whisker, lowest observation; left box border, lower quartile (25th percentile); vertical line dividing the box, median; diamonds within the box, mean; right box border, upper quartile (75th percentile); right whisker, highest observation; circles to the right of box plots, outliers.
Figure 3
Figure 3
COPD Action Plan adherence. Proportion of exacerbations in which patients took their Action Plan medication, contacted their HCP and did both, take their Action Plan medication and contact their HCP. Overall adherence was considered for exacerbations in which patients either took their medication or contacted their HCP within 72 hours of exacerbation onset. COPD, chronic obstructive pulmonary disease; HCP, healthcare professional.
Figure 4
Figure 4
Exacerbation recovery time by Action Plan adherence category. Time to recover from a COPD exacerbation in days for the following categories: (A) patients taking their COPD Action Plan medication within 72 hours of exacerbation onset; (B) patients contacting a HCP within 72 hours of exacerbation onset and (C) patients that either took their Action Plan medication or contacted their HCP within 72 hours of exacerbation onset. Box plots from top to bottom: circles above box plot, outliers; top whisker, highest observation; top box border, upper quartile (75th percentile); diamond inside box plot, mean; horizontal line dividing the box, median; bottom box border, lower quartile (25th percentile); bottom whisker, lowest observation. Results were compared with Mann-Whitney’s test; *p

References

    1. Guarascio AJ, Ray SM, Finch CK, et al. . The clinical and economic burden of chronic obstructive pulmonary disease in the USA. Clinicoecon Outcomes Res 2013;5:235–45. 10.2147/CEOR.S34321
    1. Miravitlles M, Ferrer M, Pont A, et al. . Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004;59:387–95. 10.1136/thx.2003.008730
    1. Groenewegen KH, Schols AMWJ, Wouters EFM. Mortality and mortality-related factors after hospitalization for acute exacerbation of COPD. Chest 2003;124:459–67. 10.1378/chest.124.2.459
    1. Connors AF, Dawson NV, Thomas C, et al. . Outcomes following acute exacerbation of severe chronic obstructive lung disease. The support Investigators (study to understand prognoses and preferences for outcomes and risks of treatments). Am J Respir Crit Care Med 1996;154:959–67. 10.1164/ajrccm.154.4.8887592
    1. Wilkinson TMA, Donaldson GC, Hurst JR, et al. . Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004;169:1298–303. 10.1164/rccm.200310-1443OC
    1. Bischoff EWMA, Hamd DH, Sedeno M, et al. . Effects of written action plan adherence on COPD exacerbation recovery. Thorax 2011;66:26–31. 10.1136/thx.2009.127621
    1. Effing TW, Bourbeau J, Vercoulen J, et al. . Self-management programmes for COPD: moving forward. Chron Respir Dis 2012;9:27–35. 10.1177/1479972311433574
    1. Bourbeau J, Lavoie KL, Sedeno M. Comprehensive self-management strategies. Semin Respir Crit Care Med 2015;36:630–8. 10.1055/s-0035-1556059
    1. Zwerink M, Brusse-Keizer M, van der Valk PD, et al. . Self management for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2014;36 10.1002/14651858.CD002990.pub3
    1. Bourbeau J, Julien M, Maltais F, et al. . Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med 2003;163:585–91. 10.1001/archinte.163.5.585
    1. Criner GJ, Bourbeau J, Diekemper RL, et al. . Prevention of acute exacerbations of COPD: American College of chest physicians and Canadian Thoracic Society guideline. Chest 2015;147:894–942. 10.1378/chest.14-1676
    1. Bucknall CE, Miller G, Lloyd SM, et al. . Glasgow supported self-management trial (GSuST) for patients with moderate to severe COPD: randomised controlled trial. BMJ 2012;344:e1060 10.1136/bmj.e1060
    1. Bourbeau J, Saad N, Joubert A, et al. . Making collaborative self-management successful in COPD patients with high disease burden. Respir Med 2013;107:1061–5. 10.1016/j.rmed.2013.03.003
    1. Kessler R, Casan-Clara P, Koehler D, et al. . COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD. Eur Respir J 2018;51. doi:10.1183/13993003.01612-2017
    1. Kvedar J, Coye MJ, Everett W. Connected health: a review of technologies and strategies to improve patient care with telemedicine and telehealth. Health Aff 2014;33:194–9. 10.1377/hlthaff.2013.0992
    1. Global Strategy for the Diagnosis Management and prevention of chronic obstructive pulmonary disease (2017 report), 2017.
    1. Gadoury M-A, Schwartzman K, Rouleau M, et al. . Self-management reduces both short- and long-term hospitalisation in COPD. Eur Respir J 2005;26:853–7. 10.1183/09031936.05.00093204
    1. Bourbeau J, Collet J-P, Schwartzman K, et al. . Economic benefits of self-management education in COPD. Chest 2006;130:1704–11. 10.1378/chest.130.6.1704
    1. Anthonisen NR, Connett JE, Kiley JP, et al. . Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline of FEV1. the lung health study. JAMA 1994;272:1497–505. 10.1001/jama.1994.03520190043033
    1. Calverley P, Pauwels Dagger R, Löfdahl C-G, et al. . Relationship between respiratory symptoms and medical treatment in exacerbations of COPD. Eur Respir J 2005;26:406–13. 10.1183/09031936.05.00143404
    1. Charlson ME, Pompei P, Ales KL, et al. . A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373–83. 10.1016/0021-9681(87)90171-8
    1. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease Global initiative for chronic obstructive lung disease gold, 2016.
    1. Leidy NK, Wilcox TK, Jones PW, et al. . Standardizing measurement of chronic obstructive pulmonary disease exacerbations. reliability and validity of a patient-reported diary. Am J Respir Crit Care Med 2011;183:323–9. 10.1164/rccm.201005-0762OC
    1. Bourbeau J. Disease-specific self-management programs in patients with advanced chronic obstructive pulmonary disease. Dis Manage Health 2003;11:311–9. 10.2165/00115677-200311050-00004
    1. Choi JY, Chung H-IC, Han G. Patient outcomes according to COPD action plan adherence. J Clin Nurs 2014;23:883–91. 10.1111/jocn.12293
    1. Ancochea J, García-Río F, Vázquez-Espinosa E, et al. . Efficacy and costs of telehealth for the management of COPD: the PROMETE II trial. Eur Respir J 2018;51. doi:10.1183/13993003.00354-2018
    1. Walker PP, Pompilio PP, Zanaboni P, et al. . Telemonitoring in chronic obstructive pulmonary disease (CHROMED). A randomized clinical trial. Am J Respir Crit Care Med 2018;198:620–8. 10.1164/rccm.201712-2404OC
    1. Bourbeau J, Farias R. Making sense of telemedicine in the management of COPD. Eur Respir J 2018;51. doi:10.1183/13993003.00851-2018
    1. Greene J, Hibbard JH. Why does patient activation matter? An examination of the relationships between patient activation and health-related outcomes. J Gen Intern Med 2012;27:520–6. 10.1007/s11606-011-1931-2
    1. Dale J, Connor S, Tolley K. An evaluation of the West Surrey telemedicine monitoring project. J Telemed Telecare 2003;9 39–41. 10.1258/135763303322196295
    1. Paré G, Sicotte C, St-Jules D, et al. . Cost-minimization analysis of a telehomecare program for patients with chronic obstructive pulmonary disease. Telemed J E Health 2006;12:114–21. 10.1089/tmj.2006.12.114

Source: PubMed

3
Abonner